Pharma & Biotech

Lexicon Pharmaceuticals faces a significant postponement in its regulatory timeline for Zynquista. The U.S. Food and Drug Administration (FDA) has...

Thermo Fisher Scientific finds itself at a curious crossroads, presenting investors with a mix of confident internal projections and external...

Conflicting corporate developments have placed Ocugen shares on a volatile path, torn between a significant strategic setback and a promising...

Moderna Inc. has achieved a significant manufacturing milestone, resulting in a notable uptick for its shares. The mRNA specialist announced...

Lantheus Holdings finds itself at the center of a significant legal challenge as a series of class-action lawsuits allege the...

Rhythm Pharmaceuticals finds itself at a pivotal moment, caught between promising analyst projections and a recent downtrend in its share...

The proposed acquisition of Staar Surgical by Alcon is approaching a decisive moment, marked by growing dissent from major shareholders....

Valneva SA has encountered a significant regulatory obstacle as US health authorities suspended all distribution and sales of its recently...

Telehealth provider Hims & Hers Health, Inc. finds itself navigating a dual crisis of regulatory scrutiny and a notable lack...

While KalVista Pharmaceuticals achieved a significant regulatory milestone with European and Swiss approval for its hereditary angioedema treatment EKTERLY, investors...